18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. (Q43200079)
Jump to navigation
Jump to search
scientific article published on 7 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. |
scientific article published on 7 January 2010 |
Statements
18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy (English)
Devin Schellenberg
Andy Quon
A Yuriko Minn
Edward E Graves
Pamela Kunz
George A Fisher
Karyn A Goodman
Daniel T Chang
7 January 2010